NCT02241707

Brief Summary

In this proposal, the investigators seek to determine whether a reduced compression after endovenous ablation procedure in treating superficial venous insufficiency affects the outcomes. This study involves only the use of the compression stocking post endovenous ablation procedure and everything else is standard according to current guidelines. The investigators general strategy will be to determine the role of a minimal post-operative compression and the status of patient satisfaction including (1) Success closure rate of the treated vein. (2) Less pain; (3) Easier accepted by the patients.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 11, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 16, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

April 29, 2015

Status Verified

April 1, 2015

Enrollment Period

1 year

First QC Date

September 11, 2014

Last Update Submit

April 27, 2015

Conditions

Keywords

Varicose veinEndovenous ablationCompression

Outcome Measures

Primary Outcomes (1)

  • Vein closure success rate.

    Vein closure success rate determined by clinical evidence of symptom improvement and post-procedure duplex ultrasound @ 7 days, 1, 3, 6, 12 months.

    up to 12 months.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adults, both male/female, with varicose vein who are here in our clinic to seek for endovenous ablation treatments will be invited to participate in this study.

You may qualify if:

  • Aged 18 and older
  • Diagnosis - symptoms (pain, burning, itching, cramping, heaviness and tiredness of leg, restless leg, swelling leg, etc.) and clinical signs (dilated veins, lipodermatosclerosis, color and texture changes of the skin, edema of leg, wound) correlates with vein diameter \>5.5mm and reflex (\>0.5 sec) in the upright position identified with duplex ultrasound
  • Severity/ classification - CEAP(clinical, etiologic, anatomic, and pathophysiologic) 3 or higher
  • Fail to a minimum of three months of nonoperative management (leg elevation, avoidance of prolonged standing, weight reduction, daily exercise for 30 min, prescription strength gradient compression garments, NSAIDs\<nonsteroidal antiinflammatory drug\>)
  • Post endovenous ablation (VNUS or laser) of the great saphenous vein (GSV) or small saphenous vein (SSV).

You may not qualify if:

  • Documented allergy or intolerance to compression hosiery
  • Treated vein greater than 8.5 in diameters.
  • Previous history of DVT(deep venous thrombosis); Known prothrombotic state.
  • Arterial insufficiency as determined by ABI(ankle-brachial index)\<0.5.
  • Obesity (BMI \>35, class II).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYC Surgical Associates, 555 Passaic Ave, Suite 10

West Caldwell, New Jersey, 07006, United States

Location

MeSH Terms

Conditions

Varicose VeinsVenous Insufficiency

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Jianzhong Huang, MD

    NYC Surgical Associates

    STUDY DIRECTOR
  • David A Greuner, MD

    NYC Surgical Associates

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2014

First Posted

September 16, 2014

Study Start

August 1, 2014

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

April 29, 2015

Record last verified: 2015-04

Locations